Cart
sales@molnova.com
Home - Products - Chromatin/Epigenetic - Epigenetic Reader Domain - 3-methyl-1,2-dihydroquinolin-2-one

3-methyl-1,2-dihydroquinolin-2-one

CAS No. 2721-59-7

3-methyl-1,2-dihydroquinolin-2-one( —— )

Catalog No. M28403 CAS No. 2721-59-7

3-methyl-1,2-dihydroquinolin-2-one is the first known micromolar inhibitors of the ATAD2 bromodomain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 56 In Stock
5MG 70 In Stock
10MG 105 In Stock
25MG 179 In Stock
50MG 258 In Stock
100MG 365 In Stock
200MG 496 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    3-methyl-1,2-dihydroquinolin-2-one
  • Note
    Research use only, not for human use.
  • Brief Description
    3-methyl-1,2-dihydroquinolin-2-one is the first known micromolar inhibitors of the ATAD2 bromodomain.
  • Description
    3-methyl-1,2-dihydroquinolin-2-one is the first known micromolar inhibitors of the ATAD2 bromodomain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2721-59-7
  • Formula Weight
    159.188
  • Molecular Formula
    C10H9NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1cc2ccccc2[nH]c1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Eyer P, Hell W. The metabolism of 3-benzoylpyridine. Xenobiotica. 1983 Nov;13(11):649-59. PubMed PMID: 6673376.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • ZM223

    ZM223 is a potent non-covalent inhibitor of NEDD8 activating enzyme (NAE).

  • RVX-208

    RVX-208 is a potent BET bromodomain inhibitor with IC50 of 0.510 μM for BD2 in a cell-free assay, about 170-fold selectivity over BD1. Phase 2.

  • TRIM24/BRPF1-IN-2

    TRIM24/BRPF1-IN-2 is a selective dual TRIM24/BRPF1 inhibitor with anticancer activity that inhibits proliferation, gene and protein expression, and colony formation of prostate cancer cells in a dose-dependent manner.

Sign In Join Free